Triple-negative breast cancer patients may have unique biomarker to receive targeted

[News]

Patients with triple negative breast cancer, one of the hardest subtypes to treat, may have a unique biomarker that would enable them to receive more targeted therapy, according to data presented at the Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development.

More... (http://www.news-medical.net/news/20100929/Triple-negative-breast-cancer-patients-may-have-unique-biomarker-to-receive-targeted-therapy-Research.aspx)